ABVX

73.2009.24%
JH

June H. Lee

Independent Director

Dr. June H. Lee, MD, FACCP, is Director of NKGen Biotech Korea Co., Ltd. (formerly known as NKMAX CO., Ltd.) from November 21, 2025. Dr. Lee is Independent Director of ABIVAX Société Anonyme from July 2023. Dr. Lee is Independent Director of Eledon Pharmaceuticals, Inc. from December 2020. Dr. Lee is Independent Director of Tenaya Therapeutics, Inc. from November 19, 2021. Dr. Lee was Venture Partner of 5AM Venture Management, LLC from July 2022. Dr. Lee joined the 5AM Venture Management, LLC in 2022. Dr. Lee is Independent Director of GenEdit Inc. Dr. Lee was Director of GenEdit Inc. Dr. Lee is Director of Renasant Bio, Inc. Dr. Lee was Member of Scientific Advisory Board of Foresite Labs, LLC until November 2025. Dr. Lee was employed at Foresite Labs, LLC until November 2025. Dr. Lee was Executive Officer of MyoKardia, Inc. from September 30, 2019 to June 30, 2020. Dr. Lee was Executive VP & Chief Development Officer of MyoKardia, Inc. from 2019 to September 30, 2019. Dr. Lee was COO & Chief Development Officer of MyoKardia, Inc. from October 2017. Dr. Lee was employed at MyoKardia, Inc. from February 2017 to June 30, 2020. Dr. Lee was Independent Director of CinCor Pharma, Inc. from January 2022. Dr. Lee was Member of Scientific Advisory Board of Alumis Inc. from September 2021. Dr. Lee was CEO & Director of Alumis Inc. until September 2021. Dr. Lee has M.D. from University of California, Davis, B.S. in Chemistry from Johns Hopkins University.

Positions